CARDAMIC
ActiveSummary
CARDAMIC has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €762,080 and a net result of €11,266. Equity is growing by about 3.6% per year across the filed fiscal years. The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Back to profitnet €11,266
Net result €11,266 after one loss-making year.
27-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial
Weakest financial yearnet -€5,735
Net result drops to -€5,735, the lowest in the series; recovery starts the following year.
30-06
Financial
Liquidity more than doublescurrent ratio 49.74
Current ratio from 20.81 to 49.74; short-term debt falls from €37,738 to €15,312.
26-02
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 26 days late
2023
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
09-02
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 9 days late
2021
08-02
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 8 days late
2020
30-06
Financial
Liquidity more than doublescurrent ratio 13.16
Current ratio from 5.67 to 13.16; short-term debt falls from €133,507 to €61,812.
13-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
23-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
05-02
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 5 days late
2017
02-02
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 2 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.Of the 21 annual accounts filed, the latest 10 are here; all are under Financials.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.